Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen S Chung

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|August 22, 2019
Banking on a cooperative effortStephen S Chung
Current Opinion in Hematology|January 31, 2016
Novel therapeutic strategies in myelodysplastic syndromes: do molecular genetics help?Stephen S Chung
Current Opinion in Hematology|January 22, 2014
Genetic mutations in acute myeloid leukemia that influence clinical decisionsStephen S Chung
Microrna (Shariqah, United Arab Emirates)|July 30, 2014
MicroRNA dysregulation in the myelodysplastic syndromesStephen S Chung, Christopher Y Park
Blood Advances|January 4, 2018
Aging, hematopoiesis, and the myelodysplastic syndromesStephen S Chung, Christopher Y Park
Hematology. American Society of Hematology. Education Program|December 10, 2017
Aging, hematopoiesis, and the myelodysplastic syndromesStephen S Chung, Christopher Y Park
Expert Opinion on Therapeutic Targets|April 12, 2018
Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes?Montreh Tavakkoli, Stephen S Chung, Christopher Y Park
Therapeutic Advances in Hematology|April 5, 2013
The Role of MicroRNAs in Hematopoietic Stem Cell and Leukemic Stem Cell FunctionStephen S Chung, Wenhuo Hu, Christopher Y Park
Journal of Neuropathology and Experimental Neurology|February 10, 2010
Aldose reductase deficiency improves Wallerian degeneration and nerve regeneration in diabetic thy1-YFP miceYuk Shan Chen, Stephen S Chung, Sookja K Chung
JCO Oncology Practice|August 5, 2025
Management of Anemia in Lower-Risk Myelodysplastic Syndromes/Neoplasms With Novel AgentsFieke W Hoff, Stephen S Chung, Amer M Zeidan, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|August 22, 2019
Banking on a cooperative effortStephen S Chung
Current Opinion in Hematology|January 31, 2016
Novel therapeutic strategies in myelodysplastic syndromes: do molecular genetics help?Stephen S Chung
Current Opinion in Hematology|January 22, 2014
Genetic mutations in acute myeloid leukemia that influence clinical decisionsStephen S Chung
Microrna (Shariqah, United Arab Emirates)|July 30, 2014
MicroRNA dysregulation in the myelodysplastic syndromesStephen S Chung, Christopher Y Park
Blood Advances|January 4, 2018
Aging, hematopoiesis, and the myelodysplastic syndromesStephen S Chung, Christopher Y Park
Hematology. American Society of Hematology. Education Program|December 10, 2017
Aging, hematopoiesis, and the myelodysplastic syndromesStephen S Chung, Christopher Y Park
Expert Opinion on Therapeutic Targets|April 12, 2018
Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes?Montreh Tavakkoli, Stephen S Chung, Christopher Y Park
Therapeutic Advances in Hematology|April 5, 2013
The Role of MicroRNAs in Hematopoietic Stem Cell and Leukemic Stem Cell FunctionStephen S Chung, Wenhuo Hu, Christopher Y Park
Journal of Neuropathology and Experimental Neurology|February 10, 2010
Aldose reductase deficiency improves Wallerian degeneration and nerve regeneration in diabetic thy1-YFP miceYuk Shan Chen, Stephen S Chung, Sookja K Chung
JCO Oncology Practice|August 5, 2025
Management of Anemia in Lower-Risk Myelodysplastic Syndromes/Neoplasms With Novel AgentsFieke W Hoff, Stephen S Chung, Amer M Zeidan, et al.
Pageof 5